Results: 11
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II).
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 553, doi. 10.1007/s40256-021-00473-x
- By:
- Publication type:
- Article
NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 483, doi. 10.1007/s40256-021-00471-z
- By:
- Publication type:
- Article
Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 573, doi. 10.1007/s40256-021-00476-8
- By:
- Publication type:
- Article
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 581, doi. 10.1007/s40256-021-00475-9
- By:
- Publication type:
- Article
Use of Flecainide in Stable Coronary Artery Disease: An Analysis of Its Safety in Both Nonobstructive and Obstructive Coronary Artery Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 563, doi. 10.1007/s40256-021-00483-9
- By:
- Publication type:
- Article
Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 545, doi. 10.1007/s40256-021-00470-0
- By:
- Publication type:
- Article
Antithrombotic Therapy in Peripheral Artery Disease: Stepping in the Right Direction.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 523, doi. 10.1007/s40256-021-00465-x
- By:
- Publication type:
- Article
Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 535, doi. 10.1007/s40256-021-00464-y
- By:
- Publication type:
- Article
Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 513, doi. 10.1007/s40256-020-00462-6
- By:
- Publication type:
- Article
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 499, doi. 10.1007/s40256-020-00459-1
- By:
- Publication type:
- Article
Angiotensin-Converting Enzyme Inhibitors and Contrast-Associated Acute Kidney Injury After Coronary Angiography and Intervention.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 5, p. 487, doi. 10.1007/s40256-020-00455-5
- By:
- Publication type:
- Article